Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review by Bradley, SH et al.
This is a repository copy of Sensitivity of chest X-ray for detecting lung cancer in people 
presenting with symptoms: a systematic review.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/146374/
Version: Accepted Version
Article:
Bradley, SH orcid.org/0000-0002-2038-2056, Abraham, S, Callister, MEJ et al. (5 more 
authors) (2019) Sensitivity of chest X-ray for detecting lung cancer in people presenting 
with symptoms: a systematic review. British Journal of General Practice, 69 (689). 
e827-e835. ISSN 0960-1643 
https://doi.org/10.3399/bjgp19X706853
© 2019 British Journal of General Practice. This is an author produced version of a paper 
published in the British Journal of General Practice. Uploaded in accordance with the 
publisher's self-archiving policy.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
How this fits in 
Chest x-ray remains the first line investigation for suspected lung cancer in the UK.  Outcomes for lung 
cancer are relatively poor compared to the healthcare systems of many other advanced economies, 
which make more extensive use of other imaging modalities such as CT.  This systematic review found 
that there is limited high quality evidence published on the diagnostic accuracy of chest x-ray. The few 
high quality studies identified suggest that chest x-ray misses (at least initially) lung cancer in over 20% 
of people. As earlier diagnosis is closely associated with improved survival, it is therefore possible that 
the use of chest x-ray in UK practice may delay the diagnosis of lung cancer in some patients. These 
findings support calls to increase open-access CT for GPs, but given resource restrictions and the 
potential to cause harm through over-diagnosis, further research is required to help identify which 
patients who have had a non-diagnostic chest x-ray should be referred for additional investigation.   
 
Abstract 
Background: Despite increasing use of CT, chest x-ray remains the first-line investigation for 
suspected lung cancer from primary care in the UK. No systematic review evidence exists as to the 
sensitivity of chest x-ray for detecting lung cancer in people presenting with symptoms. 
Aim: To estimate the sensitivity of chest x-ray for lung cancer in symptomatic people. 
Design and Setting: Systematic review of the sensitivity of chest x-ray for the detection of lung 
cancer. 
Method: Databases including MEDLINE, EMBASE and the Cochrane Library were searched and a grey 
literature search performed.  
Results: 21 studies met the eligibility criteria. Almost all were of poor quality. Only one study had the 
diagnostic accuracy of chest x-ray as its primary objective. Most papers were case studies with a high 
risk of bias. Several were drawn from non-representative groups e.g. specific presentations, 
histological subtypes, or co-morbidities. Only three studies had a low risk of bias. Two primary care 
studies reported sensitivities of 76.8% (95% CI: 64.5-84.2%) and 79.3% (95% CI: 67.6-91.0%). One 
secondary care study reported a sensitivity of 79.8% (95% CI: 72.7 to 86.8%). 
Conclusion: Although there is a paucity of evidence, the highest quality studies suggest that the 
sensitivity of chest x-ray for symptomatic lung cancer is only 77-79%. In high risk patients who have 
had a negative chest x-ray GPs should consider if further investigation is necessary.  
Introduction 
Lung cancer is the single largest cause of cancer mortality both worldwide (1) and in the UK (2).  
Compared to many other cancers, improvements in lung cancer survival over recent decades have 
been modest. The age standardised 5-year survival has only increased from approximately 5% to 10% 
(2) since 1971, compared to improvements from 53% to 87% in 5-year survival for breast cancer in the 
same period (3).   
 
Diagnosis of lung cancer at earlier stages of disease is associated with improved survival. Optimising 
early detection is therefore considered an important strategy in improving outcomes (4).  Chest x-ray 
is comparatively cheap, accessible (5), and has a low radiation dose (6). It remains the first-line 
investigation for lung cancer in primary care and the most common radiological route to diagnosis (7).  
This is reflected in current NICE lung cancer guidelines which recommend chest x-ray for initial 
evaluation in all patients, aside from those aged over 40 who have unexplained haemoptysis(8).  
 
Despite its predominance in guidelines and clinical practice, no systematic review has determined the 
sensitivity of chest x-ray alone for lung cancer in patients presenting with symptoms.  
 
 
  
Methods 
A systematic review was conducted in June 2017 and updated in December 2018.    
The sensitivity of chest x-ray for lung cancer was estimated by identifying studies that: 
 reported the numbers of patients who were investigated with chest x-ray due to symptoms 
in the year before their diagnosis of lung cancer, and  
 reported the contemporaneous results of the chest x-rays. 
Screening studies were not included. The authors registered the study protocol with PROSPERO (9). 
An amendment to the protocol was subsequently made to correct an error. In addition, papers were 
screened based on their title and abstract, rather than on the basis of title only, as reported in the 
protocol.  
Search strategy 
In July, 2017 we searched CINAHL, Cochrane CDSR, CENTRAL, DARE, HTA, NHS EED, Embase, Medline, 
Medline In Process and Medline Epub Ahead of Print, PubMed and Science Citation Index (SCI). These 
resources were searched with no language restrictions from 1999 using a search strategy with subject 
ｴW;Sｷﾐｪゲ ;ﾐS aヴWW デW┝デ ┘ﾗヴSゲ aﾗヴ デｴW IﾗﾐIWヮデゲ けIｴWゲデ ┝-ヴ;┞げ ;ﾐS けﾉ┌ﾐｪ I;ﾐIWヴげく  Iﾐ ﾗヴSWヴ デﾗ Wﾐゲ┌ヴW デｴ;デ 
evidence reflected contemporary radiological technology and practice, only studies published after 
1999 were included. The searches were peer reviewed, and updated in December 2018 in all the 
databases. The full search strategies can be found in supplementary material.  The reference lists of 
included papers were screened. The websites of several organisations (10-24) were manually searched 
to identify any potentially eligible reports, guidelines and audits. 
 
Inclusion & Exclusion criteria 
We considered any study which reported the number of adult patients who had a chest x-ray following 
a symptomatic presentation to a clinician in the year before diagnosis with lung cancer. The period of 
one year was selected with reference to estimates of detectable, pre-clinical phase of lung cancer 
(mean sojourn time) (25), estimated to be between 5.5 months (26) and 2.2 years (27).  Studies where 
it was unclear if the duration between chest x-ray and diagnosis was less than one year existed were 
excluded. Studies based on screening populations were excluded. Studies of patients aged under 18 
years, other intrathoracic malignancies such as mesothelioma and lymphoma, metastatic lung disease 
from a non-lung cancer primary tumour and imaging undertaken for staging or diagnostic surveillance 
for recurrent lung cancer were also excluded. In order to evaluate the diagnostic accuracy of chest x-
ray in clinical practice, we excluded studies which examined the proportion of chest x-rays where 
ﾉWゲｷﾗﾐゲ ┘WヴW けﾏｷゲゲWSげ H┌デ ｷSWﾐデｷfied in retrospect.    
 
Chest x-rays were considered positive if any abnormality considered suspicious for lung cancer was 
noted at the time of reporting and were considered negative if no features suspicious of lung cancer 
were noted at the time of reporting. Where the findings of chest x-ray were not reported in a way 
which could be classified as positive or negative according to this definition, we reported the presence 
or absence of abnormalities on the chest x-rays.    
 
We did not exclude any studies based on the reference standard used.  
 
Study selection 
Title and abstracts of all studies were screened by SB with reference to the inclusion and exclusion 
criteria.  A random 20% of all titles and abstracts were independently screened by AG. As it was 
anticipated that relevant data in some cases be would reported incidentally, rather than as a primary 
finding of studies, the reviewers maintained a low threshold for selecting citations for full text review. 
In the case of disagreements or uncertainty, a third reviewer (RN) was consulted. A full text review of 
all selected texts was undertaken by SB to determine final eligibility.   
 
 Data extraction 
Data from included studies was extracted using a form by SB including demographics and presenting 
symptoms of participants, sensitivity of chest x-ray, sample size, setting (e.g. primary or secondary 
care) and the reference standard implemented to determine true disease status.  
 
Analysis 
The outcome was the sensitivity of chest x-ray for the detection of lung cancer. This was determined 
by evaluating the stated numbers of patients in each study who presented with symptoms, who had 
chest x-ray in the year before diagnosis with lung cancer and for whom their chest x-ray had yielded a 
positive result. 95% confidence intervals for each within-study sensitivity estimate were also 
calculated. It was intended to undertake meta-analysis if possible. In the event of high between-study 
heterogeneity or a low quality of eligible studies, we planned to proceed with a descriptive synthesis 
the studies only. A modified version of  the QUADAS-2 tool (28) for diagnostic accuracy studies was  
used for quality assessment.   
 
    
  
Results 
The selection of the 21 studies (29-50) included in this review is presented in the PRISMA diagram in 
Figure 1.   Although 987 citations were selected for full text review, 187 citations could not be 
obtained despite attempts to contact authors by email.  The majority of the citations which were not 
obtained were in non-English publications (n=119, 64.6%), while a substantial proportion (n=90, 
48.1%) of these citations reported no clinical data at all in their abstracts, but were selected for full 
text review due to the comprehensive approach taken by the reviewers.    
 
The most common reason for exclusion (n=739) was that the study did not contain research or data 
that was pertinent to the study question. This included a large number (n=117) of general texts, such 
as reviews, correspondence, and educational articles which did not address the study question.   
Some citations (n=59) were excluded because the interpretation of the imaging was undertaken 
retrospectively, when the diagnosis of lung cancer was already known.  Seventeen studies were not 
eligible because patients had been chosen for inclusion on the basis of a chest x-ray that was known 
to be positive or negative for lung cancer. Four studies were ineligible because they evaluated 
individual performance at interpreting chest x-rays using films, where the presence or absence of 
lesions was already known to the study investigators. Other studies were excluded because: the 
cancers considered were not a primary lung cancer (n=44), they were case reports of a single patient 
(n=53), the duration between chest x-ray and diagnosis was greater than 1 year or unclear (n=28), 
they were drawn from screening data (n=22), or patients were under 18 years old (n=2).   
Given the high heterogeneity between studies included and their low quality, meta-analysis was not 
appropriate.     
  
Summary of eligible studies 
Twenty-one studies met the inclusion criteria (see Table 1). The number of patients in each study 
varied notably (range 2-208). Study estimates of sensitivity ranged from 0 to 100%. Most of the studies 
were case series. Estimating the diagnostic accuracy of chest x-ray for lung cancer was the primary 
objective of only one study (42).  
 
Many of the studies only included particular sub-groups of the relevant patient population, such as 
atypical tumour histology, or specific co-morbidities and symptom presentations. Of those with 
representative patient populations, only four (40, 42, 43, 49) had a sample size greater than 10. 
 
A population-based observational case series (40) identified all patients in the Danish county of Aarhus 
who had a diagnosis of lung cancer during a six month period in 2003. The purpose of the study was 
to explore reasons for diagnostic delay in lung cancer. Of 58 patients who had a chest x-ray arranged 
from general practice, 46 (79.3%) of these patients had chest x-rays which suggested the possibility of 
lung cancer including two cases in which infection was identified with a recommendation for repeat 
imaging after an appropriate interval. The remaining 12 (20.7%) chest x-rays ┘WヴW ヴWヮﾗヴデWS ;ゲ けヴ;ｷゲWS 
ﾐﾗ ゲ┌ゲヮｷIｷﾗﾐ ﾗa ﾉ┌ﾐｪ I;ﾐIWヴげく   
 
An English retrospective cohort study (42) examined chest x-ray results of 164 patients from general 
practices in a Primary Care Trust diagnosed with lung cancer between January 1998 and September 
2002 (aged 40 or over). In over three-quarters (n=126, 76.8%), the chest x-ray indicated the possibility 
of lung cancer, while 38 (23.1ΑХぶ ヮ;デｷWﾐデゲ ｴ;S ; けﾐWｪ;デｷ┗Wげ IｴWゲデ ┝-ヴ;┞く Oa デｴW ンΒ けﾐWｪ;デｷ┗Wげ IｴWゲデ ┝-
rays, 21 (12.8%) were categorised as abnormal but not suspicious of malignancy while 17 (10.4%) were 
ヴWヮﾗヴデWS ;ゲ けﾐﾗヴﾏ;ﾉげく      
 
A retrospective case note review of all patients diagnosed with lung cancer in a Spanish centre from 
January 2001 to September 2006 included 102 patients who had a chest x-ray before diagnosis (43).  
Aﾐ け;Hﾐﾗヴﾏ;ﾉｷデ┞げ ┘;ゲ ヮヴWゲWﾐデ ﾗﾐ ΓΑ ふΓヵくヱХぶ ﾗa デｴW ヮ;デｷWﾐデゲげ IｴWゲデ ┝-rays; however this could not be 
IﾗﾐゲｷSWヴWS ゲ┞ﾐﾗﾐ┞ﾏﾗ┌ゲ ┘ｷデｴ けゲWﾐゲｷデｷ┗ｷデ┞げ ;ゲ デｴW ;┌デｴﾗヴゲ SｷS ﾐﾗデ ｷﾐSｷI;デW ┘ｴｷIｴ ﾗa デｴW ;Hﾐﾗヴﾏ;ﾉｷデｷWゲ 
were considered to be suspicious for lung cancer when they were reported.  The abnormalities were 
nodules or masses in 53 cases (52.0%), pleural effusions in 16 (15.7%), an enlarged hilum in 16 (15.7%), 
multiple pulmonary metastasis in 6 (5.9%), a widened mediastinum 4 (3.9%), and an interstitial 
infiltration in 2 (2.0%).   
     
Finally, a conference abstract reported a retrospective review of chest x-ray reports in a secondary 
care setting in the Republic of Ireland (49).  Of 158 patients, 126 (79.8%) were identified as likely to 
have a lung malignancy and/or advised to have repeat imaging. A further 23 patients had a chest x-
ray in ┘ｴｷIｴ デｴW ;┌デｴﾗヴゲ ヴWaWヴ デﾗ ;ゲ けﾉWゲｷﾗﾐ ﾐﾗデ ｷSWﾐデｷaｷWSげ ふヱヴくヶХぶ ;ﾐS Γ ｷﾐ ┘ｴｷIｴ ;ﾐ ;Hﾐﾗヴﾏ;ﾉｷデ┞ ┘;ゲ 
identified but no follow up recommended (5.7%).   
Quality Assessment 
Assessment of quality was undertaken by SB and AG using a modified version of the QUADAS-2 tool 
(29) with disagreements between reviewers resolved through discussion.  Three studies (40, 42, 49 ) 
were deemed to  have a low risk of bias.  A further study (43) was deemed to have a low risk of bias 
in the selection of patients, however the reporting of chest x-ray result as normal or abnormal, 
rather than suspicious or not suspicious for lung cancer resulted in limited applicability for this 
review.  The majority of studies (17, 81.0%) were deemed to be have a high risk of bias.  In 
particular, many (14, 66.7%) included particular sub-groups of the relevant patient population, such 
as atypical tumour histology, or specific co-morbidities and symptom presentations.  .   
  
Discussion 
Summary 
This systematic review identified three studies which reported sensitivity of chest x-ray and which had 
a low risk of bias.. The sensitivity estimates for these studies were: 79.3%  (95% CI: 67.6-91.0%)  (41), 
76.8% (95% CI: 64.5-84.2%) (43) and 79.8% (95% CI: 72.7-86.8%). (50).  
 
These results suggest that chest x-ray fails to identify lung cancer (at least initially) in over 20% of 
people who are subsequently diagnosed with lung cancer. All three of these studies were conducted 
in countries with broadly similar primary care systems (Denmark, England, Republic of Ireland). Two 
of these studies (40, 42) were derived from primary care settings and, although the remaining study 
(49) was from a secondary care radiology department, it is likely that many of the chest x-rays 
performed resulted from primary care referrals.   
 
Strengths and limitations 
This review featured a sensitive and comprehensive search of bibliographic databases and grey 
literature in order to identify published and unpublished sources.  This study is highly relevant both to 
national cancer policy and everyday clinical practice. With approximately 46,700 new diagnoses of 
lung cancer in the UK per year (2), of which approximately 56% are diagnosed following referral for 
chest x-ray (7), our findings suggest that false-negative chest x-rays could contribute to a delayed 
diagnosis for several thousand patients each year.   
Diagnostic accuracy was the stated primary outcome of only one study; in most included studies an 
estimate of sensitivity was estimated from the data reported. These studies were therefore at high 
risk of bias. Indeed, none conformed to the conventional standards of diagnostic accuracy studies (51). 
While the best available evidence was selected for analysis, many other eligible studies were of poor 
quality making meta-analysis inappropriate. In order to identify all relevant evidence, the review 
included studies from different settings. The different disease prevalence in primary and secondary 
care is known to impact on test performance (52) which could not be accounted for in this review.  
However, the consistency in the sensitivity estimates from the higher quality studies is striking.  Due 
to the large number of citations, selection was peer reviewed in only 20% of cases and data extraction 
was conducted by one researcher.  187 citations could not be obtained, reflecting the broad search 
strategy used and the low threshold used for selection for full text review. Only about half of those 
papers (n=97, 51.2%) contained any study data in their abstracts.      
 
Comparisons with Existing Literature  
Several studies have evaluated the performance of chest x-ray by re-examining radiographs in the light 
of a known lung cancer diagnosis. While such studies were not eligible for this review, that literature 
provides an important context. Notably, a Dutch retrospective review of radiographs of non-small cell 
lung cancer cases (n=495) reported that ヱΓХ ｴ;S ; ﾐﾗS┌ﾉ;ヴ ﾉWゲｷﾗﾐ ┘ｴｷIｴ ｴ;S HWWﾐ けﾏｷゲゲWSげ (53).    
 
Iデ ｷゲ ヮﾗゲゲｷHﾉW デｴ;デ ﾉ┌ﾐｪ I;ﾐIWヴゲ ﾏ;┞ ﾐﾗデ ｴ;┗W HWWﾐ ヮヴWゲWﾐデ ┘ｴWﾐ ｷﾏ;ｪｷﾐｪ ﾗII┌ヴヴWS ふけｷﾐデWヴ┗;ﾉ I;ﾐIWヴゲげぶく 
A large screening trial concluded that of those cancers which were not detected on screening chest x-
ray but subsequently diagnosed within one year, the lung cancer was not visible, even in retrospect, 
in 65% of cases (54).    
 
A ゲWヮ;ヴ;デW ﾉｷデWヴ;デ┌ヴW ｴ;ゲ W┝ヮﾉﾗヴWS デｴW ヴﾗﾉW ﾗa けﾗHゲWヴ┗Wヴ Wヴヴﾗヴげ ｷﾐ a;ｷﾉｷﾐｪ デﾗ ヴWIﾗｪﾐｷゲW I;ﾐIWヴゲ ┘ｴｷIｴ 
were evident in retrospect.  Inexperience, poor technique in visual scanning of the image, failures in 
recognising abnormalities and of decision making along with lapses of concentration have all been 
ｷSWﾐデｷaｷWS ;ゲ a;Iデﾗヴゲ IﾗﾐデヴｷH┌デｷﾐｪ デﾗ けﾏｷゲゲWSげ ﾉ┌ﾐｪ I;ﾐIWヴゲ ﾗﾐ IｴWゲデ ┝-ray (55, 56).   
 
Other studies have considered the characteristics of lesions which may make them less identifiable. 
Smaller tumours are identified much less frequently; lesions measuring less than 1cm in diameter are 
particularly likely to be missed on chest x-ray compared to other modalities such as CT (53).   
 
Location is also important, with missed lung cancers frequently located in the upper lobes (53, 57-60) 
or obscured by overlying anatomy such as ribs, lung vasculature and heart.  Many missed cancers are 
located in the hilar regions, where the confluence of complex anatomy makes diagnosis particularly 
challenging (55).  The technical quality of the radiograph itself and the positioning of the patient are 
additional factors that can influence the likelihood of successful detection of lung cancer on chest x-
ray (61).  
 
Implications for research and practice 
Chest x-ray retains a predominant role in the UK clinical practice and guidance for the diagnosis of 
lung cancer (62). Most lung cancers are diagnosed following suspicious findings on chest x-ray (7) and 
increasing the use of chest x-ray in primary care has been associated with diagnosis at an earlier stage 
and reduced mortality (63). However, this review suggests that chest x-ray may have a false-negative 
rate of at least 20%. GPs should take limited reassurance from a non-diagnostic chest x-ray and 
consider additional imaging or referral of those at high risk, or re-imaging in the face of continuing 
symptoms. If chest x-ray were a novel technology, it is debatable whether the available evidence 
would be deemed sufficient to support its implementation as a diagnostic test for lung cancer. In order 
デﾗ ｷﾏヮヴﾗ┗W デｴW UKげゲ ﾉ┌ﾐｪ I;ﾐIWヴ ﾗ┌デIﾗﾏWゲ, diagnostic strategies may necessitate widening access to 
more definitive modalities, such as CT.  While this study has demonstrated a significant false negative 
rate for chest x-ray it is important to recognise that the benefits of increased rates of CT investigation 
must be balanced against known harms including over-diaｪﾐﾗゲｷゲ ;ﾐS けa;ﾉゲW ヮﾗゲｷデｷ┗Wゲげ (64),   Future 
work is required to determine which patients can be reasonably followed up by safety netting 
following an unremarkable chest x-ray and which patients require further investigation.  
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